Aurora Spine (TSXV:ASG) Research & Development: C$0.80 Mil (TTM As of Mar. 2026)


TSXV:ASG Aurora Spine Corp TSXV:ASG
41 GF Score
Price C$0.23
GF Value C$0.32
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Aurora Spine Research & Development?

Aurora Spine TSXV:ASG 41 Research & Development is C$0.80 Mil as of Mar. 2026. GuruFocus rates TSXV:ASG with a GF Score™ of 41/100 and a GF Value™ of C$0.32 (Modestly Undervalued). The stock has 4 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Aurora Spine's Research & Development for the three months ended in Mar. 2026 was C$0.15 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was C$0.80 Mil.

Aurora Spine  (TSXV:ASG) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Aurora Spine Research & Development Related Terms

Aurora Spine Research & Development Historical Data

* Premium members only.

The historical data trend for Aurora Spine's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aurora Spine Research & Development Chart

Aurora Spine Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.20 1.58 1.50 1.04 0.86

Aurora Spine Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.22 0.23 0.28 0.14 0.15
TSXV:ASG
41GF Score
Aurora Spine Corp TSXV:ASG
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Aurora Spine Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.80 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of C$0.80 Mil mean?
Aurora Spine (TSXV:ASG) has a Research & Development of C$0.80 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Aurora Spine and its competitors.
Is Aurora Spine's Research & Development too high?
Aurora Spine's current Research & Development is C$0.80 Mil. Overall, Aurora Spine has a GF Score™ of 41/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Aurora Spine's Research & Development compare to ABT and SYK?
Aurora Spine's Research & Development of C$0.80 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Medical Devices & Instruments company?
A good Research & Development depends on the Medical Devices & Instruments industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Aurora Spine and its competitors. Aurora Spine's current Research & Development is C$0.80 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aurora Spine stock overvalued right now?
Based on GuruFocus' analysis, Aurora Spine (TSXV:ASG) is currently considered Modestly Undervalued. The stock's GF Value™ is C$0.32, compared to a current price of C$0.23 — trading 28.1% below its estimated fair value. The current Research & Development is C$0.80 Mil. Aurora Spine's overall GF Score™ is 41/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Aurora Spine (TSXV:ASG), the current Research & Development is C$0.80 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Aurora Spine (TSXV:ASG) Overvalued in 2026?

Based on GuruFocus' analysis, Aurora Spine stock appears to be undervalued. The current stock price of C$0.23 is trading 28.1% below its estimated GF Value™ of C$0.32. GuruFocus considers Aurora Spine to be Modestly Undervalued.

Key valuation signals for TSXV:ASG:

  • Research & Development: C$0.80 Mil
  • GF Value™: C$0.32 vs. price of C$0.23 (28.1% below fair value)
  • GF Score™: 41/100 with 4 warning signs

No single metric tells the full story. See the TSXV:ASG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Aurora Spine Business Description

Other Exchanges ASAPF:USA
Address 20 Holly Street, Suite 300, Toronto, ON, CAN, M4S 3B1
Aurora Spine Corp is engaged in the development, manufacture, and sale of minimally invasive, interspinous fusion systems and devices. These 510K and patent protected medical devices improve patient outcomes in the area of spine and sacroiliac joint surgical procedures. The company is focused on bringing new solutions to the spinal implant market through a series of minimally invasive, regenerative spinal implant technologies.
41GF Score

Get the complete analysis for TSXV:ASG

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

C$0.23
Price
C$0.32
GF Value